Highlights

  • Effectiveness of Oseltamivir on 30-day readmissions and mortality in hospitalized influenza patients is unknown.
  • This study compared outcomes with early administration (<48 h) of Oseltamivir versus late treatment (>48 h) or no treatment.
  • Early administration of Oseltamivir reduces 30-day readmissions but not 30-day mortality.
  • Early administration of Oseltamivir also reduces the length of hospital stay.

Read more…